The Department of Infectious Diseases at the Medical College of Georgia at Augusta
University conducts Clinical Trials relating to a wide variety of pertinent infectious
diseases. The following is a non-comprehensive list of currently active studies in
the department. If you are interested in learning more about a specific study, please
contact the study coordinator listed for the study and we would be more than happy to provide
you will further details.
ClinicalTrials.gov#
|
Official Title
|
Primary Investigator
|
Study Coordinator
|
ANCT04439071
|
Evaluation of the Efficacy and Safety of PTC299 in Hospitalized Subjects With COVID-19
(FITE19) |
Jose Vazquez |
Aprile Osborn |
NCT04340388 |
Contribution of the Integrase Inhibitor Dolutegravir to Obesity and Cardiovascular
Disease in Persons Living With HIV |
Jonell Poe |
Ryan Harris Amber Ladak Reva Crandall Jacob Looney
|
NCT04633187
|
A Phase 2b, Randomized, Double-Blind, Placebo-Controlled Study Evaluating the Effects
of EDP-938 in Adult Hematopoietic Cell Transplant Recipients With Acute Respiratory
Syncytial Virus Infection of the Upper Respiratory Tract |
Andrew Chao |
Aprile Osborn |
NCT04442737 |
A Phase 4, Randomized, Active-Controlled, Open-label Study to Evaluate the Safety
and Tolerability of Switching to Once-Daily Darunavir/Cobicistat/Emtricitabine/Tenofovir
Alafenamide (D/C/F/TAF) Fixed-dose Combination (FDC) Regimen in Virologically-suppressed
Human Immunodeficiency Virus Type 1 (HIV-1) Infected Participants Experiencing Rapid
Weight Gain With an INI + TAF/FTC ARV Regimen |
Cheryl Newman |
Angela Stroman |
NCT03059992 |
Open-Label Study to Evaluate the Efficacy and Safety of SCY-078 (Ibrexafungerp) in
Patients With Fungal Diseases That Are Refractory to or Intolerant of Standard Antifungal
Treatment (FURI) |
Jose Vazquez |
Aprile Osborn |
NCT04160468 |
A Randomized, Double-Blind, Placebo-Controlled Study of the Efficacy and Safety of
a Single Dose of Exebacase in Patients Receiving Standard-of-Care Antibiotics for
the Treatment of Staphylococcus Aureus Bloodstream Infections (Bacteremia), Including
Right-Sided Infective Endocarditis (DISRUPT) |
Jose Vazquez |
Aprile Osborn |
NCT04650087 |
ACTIV-4C: A multicenter, adaptive, prospective, randomized trial evaluating the efficacy
and safety of antithrombotic strategies in patients with COVID-19 following hospital
discharge
|
Jose Vazquez |
Ashton Bowles |
NCT02735707 |
Randomized, Embedded, Multifactorial Adaptive Platform Trial for Community-Acquired
Pneumonia (REMAP-CAP)
|
Jose Vazquez |
Ashton Bowles |